Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glioblastoma (GBM)”

2,222 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,222 results

Early research (Phase 1)Active Not RecruitingNCT05739942
What this trial is testing

Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma

Who this might be right for
Newly Diagnosed and Recurrent Glioblastoma
Novartis Pharmaceuticals 42
Testing effectiveness (Phase 2)Study completedNCT01067469
What this trial is testing

Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM)

Who this might be right for
Brain CancerGlioblastoma
M.D. Anderson Cancer Center 83
Not applicableNot Yet RecruitingNCT06781372
What this trial is testing

Patient's Derived Organoids for Drug Screening in Glioblastoma

Who this might be right for
GlioblastomaGlioblastoma Multiforme (GBM)Glioblastoma Multiforme, Adult
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 100
Testing effectiveness (Phase 2)Study completedNCT03310372
What this trial is testing

Concomitant Association of Ultrafractionated Brain Irradiation - Temozolomide in Inoperable Primary Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Central Hospital, Nancy, France 46
Not applicableStudy completedNCT04610229
What this trial is testing

Safety of IMRT Treatment With Inhomogeneous Dose in Patients With Relapsed High-grade Gliomas.

Who this might be right for
Glioblastoma MultiformeGlioblastomaGlioblastoma, Adult
Azienda USL Reggio Emilia - IRCCS 12
Early research (Phase 1)UnknownNCT04385173
What this trial is testing

Pilot Study of B7-H3 CAR-T in Treating Patients With Recurrent and Refractory Glioblastoma

Who this might be right for
Recurrent GlioblastomaRefractory Glioblastoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 12
Testing effectiveness (Phase 2)Study completedNCT02858895
What this trial is testing

Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma

Who this might be right for
GlioblastomaGrade IV AstrocytomaGlioblastoma Multiforme+1 more
Medicenna Therapeutics, Inc. 47
Early research (Phase 1)Study completedNCT00003409
What this trial is testing

Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Looking for participantsNCT05139056
What this trial is testing

Multiple Intracerebral Doses of Neural Stem Cell-Based Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas

Who this might be right for
Currently Only Enrolling Glioblastoma Patients at First Recurrence
City of Hope Medical Center 36
Early research (Phase 1)Study completedNCT00120939
What this trial is testing

Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer

Who this might be right for
Breast NeoplasmsOvarian NeoplasmsProstatic Neoplasms+2 more
Pharmacyclics LLC. 25
Not applicableEnded earlyNCT03287063
What this trial is testing

Study Using Genomic, Histologic and Radiomic Analysis to Evaluate Regional Tumor Heterogeneity in Patients Undergoing Surgery for Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
University of Michigan Rogel Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT00919737
What this trial is testing

Study of NPC-08 is to Treat for Newly-Diagnosed Malignant Glioma and Recurrent Glioblastoma Multiforme

Who this might be right for
Malignant Glioma
Nobelpharma 24
Testing effectiveness (Phase 2)Study completedNCT01290692
What this trial is testing

Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma

Who this might be right for
Grade IV GliomaGrade IV AstrocytomaGlioblastoma Multiforme
TVAX Biomedical 14
Large-scale testing (Phase 3)Study completedNCT01811121
What this trial is testing

MEDICO-ECONOMIC EVALUATION OF SURGERY GUIDED BY FLUORESCENCE FOR THE OPTIMIZATION OF RESECTION OF GLIOBLASTOMAS

Who this might be right for
Glioblastoma
Hospices Civils de Lyon 170
Early research (Phase 1)Study completedNCT00509301
What this trial is testing

Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Recurrent Glioblastoma Multiforme
Peregrine Pharmaceuticals 12
Not applicableActive Not RecruitingNCT05818865
What this trial is testing

"Principle Test" for Isolation and Characterization of Circulating Cancer Cells (CTC)-CXCR4+.

Who this might be right for
Neoplasm Malignant
National Cancer Institute, Naples 47
Testing effectiveness (Phase 2)Active Not RecruitingNCT04881032
What this trial is testing

AGuIX Nanoparticles With Radiotherapy Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Centre Jean Perrin 66
Early research (Phase 1)Active Not RecruitingNCT04555577
What this trial is testing

Phase I Trial of DNA-PK Inhibitor (PEPOSERTIB ) in Combination With Radiation and Adjuvant Temozolomide in Newly Diagnosed MGMT Unmethylated and Recurrent Glioblastoma

Who this might be right for
GlioblastomaGliosarcoma
M.D. Anderson Cancer Center 29
Not applicableUnknownNCT03225300
What this trial is testing

Simultaneous Integrated Boost in Malignant Glioma Patients Treated With Chemoradiation

Who this might be right for
Glioblastoma MultiformeChemoradiation
Taichung Veterans General Hospital 120
Testing effectiveness (Phase 2)Study completedNCT03879512
What this trial is testing

Autologous Dendritic Cells, Metronomic Cyclophosphamide and Checkpoint Blockade in Children With Relapsed HGG

Who this might be right for
Childhood Glioblastoma
Wuerzburg University Hospital 24
Next Page